Clinical trial
Impact of M22 Synergistic Sequential Treatment (SST) Using Intense Pulsed Light and Fractional Non-ablative Photothermolysis on Skin Texture
NCT02032771 is registered in ClinicalTrials.gov with Lumenis Be Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of M22 Synergistic Sequential Treatment (SST) Using Intense Pulsed Light and Fractional Non-ablative Photothermolysis on Skin Texture
- Lead sponsor
- Lumenis Be Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- February 29, 2016
- Enrollment
- 33 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
improvement of wrinkles/elastosis and/or pigmentation